Begin typing your search...
Prospective batch pricing will provide impetus to pharma industry
NPPA urged to exempt control formulations on products priced below Rs 5 per unit
Imperative to take a call on ‘bedaquiline’ to achieve TB-free India
Beacon of hope came with the introduction of two wonder oral drugs in 2013
Pharma exporters stand to gain from Commerce ministry’s amnesty
Good opportunity to get peace of mind from harrowing pending default cases
Time to rework on PTUAS norms to make it industry-friendly
Launched on July 21, 2022, the DoP scheme is aimed at strengthening pharma MSMEs
Supply of Cabotegravir must be mandated to combat new HIV infections
ViiV should register CAB-LA globally as the most vulnerable nations are denied access to the wonder drug
Higher FDI inflow augurs well for pharma industry
The fund infusion by foreign investors into the sector for the period from April to December, 2022 stood at $1.82 bn as compared to the whole year...
In the absence of regulations, e-pharmacists go for the kill
Public health at risk due to unlicenced sales across online, internet, mobile Apps and other electronic platforms despite DCGI orders and court...
